Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 1451 to 1460 of 2417

TitleReference numberPublishedLast updated
Nivolumab for advanced non-squamous non-small-cell lung cancer after chemotherapyTA713
Nivolumab for advanced squamous non-small-cell lung cancer after chemotherapyTA655
Nivolumab for previously treated advanced renal cell carcinomaTA417
Nivolumab for previously treated unresectable advanced or recurrent oesophageal cancerTA707
Nivolumab for treating advanced (unresectable or metastatic) melanomaTA384
Nivolumab for treating locally advanced unresectable or metastatic urothelial cancer after platinum-containing chemotherapyTA530
Nivolumab for treating recurrent or metastatic squamous cell carcinoma of the head and neck after platinum-based chemotherapyTA736
Nivolumab for treating relapsed or refractory classical Hodgkin lymphomaTA462
Nivolumab in combination with ipilimumab for treating advanced melanomaTA400
Nivolumab with cabozantinib for untreated advanced renal cell carcinoma (terminated appraisal)TA785

Results per page

  1. 10
  2. 25
  3. 50
  4. All